| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |